Midas List 2026: Submissions Open To Rank The World’s Leading Venture Capitalists

The definitive ranking of the 100 best tech investors in the world, the Forbes Midas List is now seeking submissions for its landmark 25th annual edition through January 23rd.

Why Prediction Markets Need Insider Trading

An outcry over insider trading erupted after one Polymarket user made $400,000 betting that Maduro would be ousted, hours before it happened. Here’s why the godfather of prediction markets thinks it’s a good thing.

Founder Of Chinese AI Model Developer MiniMax Becomes A Billionaire As Shares Surge On Listing

Yan Junjie, the 36-year-old chairman and CEO of MiniMax, now boasts a net worth of $3.2 billion after the AI model developer’s $618 million Hong Kong IPO.

Dreame Launches A Large Ecosystem Of Smart Products For Every Aspect Of Life

At CES 2026, Dreame introduced over 30 products that range from action cameras to AI vacuum cleaners to a concept car.

I Tried Navee’s New Flagship Scooter And It’s Impressive, But The Company Has Sights On More

At CES 2026, Navee introduced a new flagship electric scooter and a slew of other mobility products.

Leion Hey 2 Are Sleek Translation Glasses With A Discreet Screen

Launched at CES 2026, the pair of lightweight glasses support translation and transcription of over 100 languages.

TCL’s Note A1 NXTPAPER Is An Excellent Device For Handwriting And Drawing

The tablet, which offers a screen that resembles an e-ink display, is designed to be a productivity tool.

This CEO’s $1.7 Billion Health Startup Began With Moms. Now She Wants To Expand To All Women.

Former Flatiron Health exec Marta Bralic Kerns raised $92 million to expand her virtual care model to women at all stages of their lives.

Chinese OpenAI Challenger Zhipu’s IPO Mints New Billionaire

Zhipu, which operates a ChatGPT-like service called Z.ai, raised $558 million in the IPO. Its chairman, Liu Debing, amassed a fortune of $2.1 billion based on his stake in the Chinese AI model company.

Measles And Flu Hit New Highs As Trump Administration Hammers Vaccines

In this week’s edition of InnovationRx, we look at a former Wall Street analyst’s $4 billion obesity drug company, Wegovy’s weight-loss pill, and more.